## AFL: Aflac Incorporated - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.4% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($106.54)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bearish (Bullish: 0, Bearish: 1)

**1. Aflac (NYSE:AFL) Price Target Raised to $102.00**
- Source: MarketBeat | 20251222T162804 | Neutral | Relevance: 100%
- TD Cowen raised Aflac's (NYSE:AFL) price target to $102.00 from $100.00, maintaining a "hold" rating, though this implies a 7.79% potential downside from the current price, with the Street's consensus price target at $109.83. Other analysts also adjusted their price targets, and institutional investors have significantly increased their holdings, while company insiders made some sales. Aflac currently trades at $110.62 with a market cap of $57.98 billion.

**2. Aflac: 22.6M impacted in cybersecurity breach**
- Source: The Guam Daily Post | 20251221T075307 | Bearish | Relevance: 100%
- Aflac Inc. has informed customers about a cybersecurity breach that impacted 22.65 million individuals, including customers, beneficiaries, employees, and agents. The breach, which occurred on June 12, 2025, involved an "unauthorized actor" accessing personal information such as names, contact information, health information, and social security numbers. Aflac is offering 24 months of free identity theft and credit monitoring services through CyEx Medical Shield to those affected.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | TD Cowen | $102 | $100 | +2% |
| 2025-12-16 | Mizuho | $104 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | TD Cowen | main | Hold |
| 2025-12-16 | Mizuho | init | Underperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.18M) |
| Sells | 10 ($3.46M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.3% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Japan Post Holdings : 10.0% (0.0%)
- Vanguard Group Inc: 9.6% (-0.8%)
- Blackrock Inc.: 7.4% (+0.1%)
- State Street Corpora: 4.6% (+0.1%)
- Wells Fargo & Compan: 2.1% (-24.6%)

### Key Risks

1. Insider selling cluster: $3.5M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.93 indicates undervaluation relative to growth. Quality metrics strong (margin 24%). Balance sheet: strong liquidity (48.2x). Insider selling cluster ($3.5M in 90 days), potential headwind. Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $58.9B |
| Beta | 0.66 |
| 52W Range | $96.95 - $115.84 |
| Short Interest | 1.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.93 |
| Forward P/E | 14.9 |
| Current P/E | 14.5 |
| YoY Growth | -2.7% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 1.7% to -0.4% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.4pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 50. OFD pattern: +DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.41% (CS: 44) | Neutral |
| RSI_14 | 50.2 | Neutral |
| MACD Histogram | 0.14 | Bullish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 1.001x | Above |
| vs SMA200 | 1.030x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $110.00
- **Stop Loss:** $106.54 (3.1% risk)
- **Target:** $113.46 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 260
- **Position Value:** $28,600.00
- **Portfolio %:** 28.60%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-04 (Est: $1.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.78 | $2.49 | +40.2% |
| 2025Q2 | $1.71 | $1.78 | +4.3% |
| 2025Q1 | $1.67 | $1.66 | -0.8% |
| 2024Q4 | $1.62 | $1.56 | -3.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*